These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 38790051)

  • 1. IL-37 ameliorates myocardial fibrosis by regulating mtDNA-enriched vesicle release in diabetic cardiomyopathy mice.
    Huang Q; Chen T; Li J; Wang Y; Shi H; Yu Y; Ji Q; Shen X; Sun T; Shi H; Luo X; Jin B; You Y; Wu B
    J Transl Med; 2024 May; 22(1):494. PubMed ID: 38790051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Farrerol Alleviates Diabetic Cardiomyopathy by Regulating AMPK-Mediated Cardiac Lipid Metabolic Pathways in Type 2 Diabetic Rats.
    Tu J; Liu Q; Sun H; Gan L
    Cell Biochem Biophys; 2024 Sep; 82(3):2427-2437. PubMed ID: 38878100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rosmarinic acid ameliorated cardiac dysfunction and mitochondrial injury in diabetic cardiomyopathy mice via activation of the SIRT1/PGC-1α pathway.
    Diao J; Zhao H; You P; You H; Wu H; Shou X; Cheng G
    Biochem Biophys Res Commun; 2021 Mar; 546():29-34. PubMed ID: 33561745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Triad3A-Mediated K48-Linked ubiquitination and degradation of TLR9 impairs mitochondrial bioenergetics and exacerbates diabetic cardiomyopathy.
    Kong C; Guo Z; Liu F; Tang N; Wang M; Yang D; Li C; Yang Z; Ma Y; Wang P; Tang Q
    J Adv Res; 2024 Jul; 61():65-81. PubMed ID: 37625569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipotoxicity-induced mtDNA release promotes diabetic cardiomyopathy by activating the cGAS-STING pathway in obesity-related diabetes.
    Ma XM; Geng K; Law BY; Wang P; Pu YL; Chen Q; Xu HW; Tan XZ; Jiang ZZ; Xu Y
    Cell Biol Toxicol; 2023 Feb; 39(1):277-299. PubMed ID: 35235096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exercise Prevents Cardiac Injury and Improves Mitochondrial Biogenesis in Advanced Diabetic Cardiomyopathy with PGC-1α and Akt Activation.
    Wang H; Bei Y; Lu Y; Sun W; Liu Q; Wang Y; Cao Y; Chen P; Xiao J; Kong X
    Cell Physiol Biochem; 2015; 35(6):2159-68. PubMed ID: 25896313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human umbilical cord-derived mesenchymal stromal cells improve myocardial fibrosis and restore miRNA-133a expression in diabetic cardiomyopathy.
    Liu B; Wei Y; He J; Feng B; Chen Y; Guo R; Griffin MD; Hynes SO; Shen S; Liu Y; Cui H; Ma J; O'Brien T
    Stem Cell Res Ther; 2024 Apr; 15(1):120. PubMed ID: 38659015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LARP7 Contributes to Glucose-Induced Cardiac Dysfunction, Apoptosis and Fibrosis by Inhibiting the Degradation of STING.
    Sun J; Wang Z; Duan Y; Liu C; Zhao S; Deng J
    Front Biosci (Landmark Ed); 2024 Jul; 29(7):274. PubMed ID: 39082350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Role of Heme Oxygenase 1 in the Protective Effect of Caloric Restriction against Diabetic Cardiomyopathy.
    Waldman M; Nudelman V; Shainberg A; Zemel R; Kornwoski R; Aravot D; Peterson SJ; Arad M; Hochhauser E
    Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31100876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FNDC5/Irisin attenuates diabetic cardiomyopathy in a type 2 diabetes mouse model by activation of integrin αV/β5-AKT signaling and reduction of oxidative/nitrosative stress.
    Lin C; Guo Y; Xia Y; Li C; Xu X; Qi T; Zhang F; Fan M; Hu G; Zhao H; Zhao H; Liu R; Gao E; Yan W; Tao L
    J Mol Cell Cardiol; 2021 Nov; 160():27-41. PubMed ID: 34224725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tectorigenin protects against cardiac fibrosis in diabetic mice heart via activating the adiponectin receptor 1-mediated AMPK pathway.
    Ma YL; Xu M; Cen XF; Qiu HL; Guo YY; Tang QZ
    Biomed Pharmacother; 2024 May; 174():116589. PubMed ID: 38636400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nimbolide protects against diabetic cardiomyopathy by regulating endoplasmic reticulum stress and mitochondrial function via the Akt/mTOR pathway.
    Zhang H; Zhao X; Wei W; Shen C
    Tissue Cell; 2024 Oct; 90():102478. PubMed ID: 39053131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advanced glycation end-products impair Na⁺/K⁺-ATPase activity in diabetic cardiomyopathy: role of the adenosine monophosphate-activated protein kinase/sirtuin 1 pathway.
    Yuan Q; Zhou QY; Liu D; Yu L; Zhan L; Li XJ; Peng HY; Zhang XL; Yuan XC
    Clin Exp Pharmacol Physiol; 2014 Feb; 41(2):127-33. PubMed ID: 24341361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth differentiation factor 11 regulates high glucose-induced cardiomyocyte pyroptosis and diabetic cardiomyopathy by inhibiting inflammasome activation.
    Zhang J; Wang G; Shi Y; Liu X; Liu S; Chen W; Ning Y; Cao Y; Zhao Y; Li M
    Cardiovasc Diabetol; 2024 May; 23(1):160. PubMed ID: 38715043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiomyocyte-derived small extracellular vesicle: a new mechanism driving diabetic cardiac fibrosis and cardiomyopathy.
    Li Y; Du Y; Liu Y; Chen X; Li X; Duan Y; Qin Y; Liu H; Ma X; Nie S; Zhang H
    Theranostics; 2024; 14(15):5926-5944. PubMed ID: 39346544
    [No Abstract]   [Full Text] [Related]  

  • 16. Attenuation of diabetic cardiomyopathy by relying on kirenol to suppress inflammation in a diabetic rat model.
    Wu B; Huang XY; Li L; Fan XH; Li PC; Huang CQ; Xiao J; Gui R; Wang S
    J Cell Mol Med; 2019 Nov; 23(11):7651-7663. PubMed ID: 31565849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FGF21 ameliorates diabetic cardiomyopathy by activating the AMPK-paraoxonase 1 signaling axis in mice.
    Wu F; Wang B; Zhang S; Shi L; Wang Y; Xiong R; Pan X; Gong F; Li X; Lin Z
    Clin Sci (Lond); 2017 Aug; 131(15):1877-1893. PubMed ID: 28559425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SIRT6‑specific inhibitor OSS‑128167 exacerbates diabetic cardiomyopathy by aggravating inflammation and oxidative stress.
    Huang Y; Zhang J; Xu D; Peng Y; Jin Y; Zhang L
    Mol Med Rep; 2021 May; 23(5):. PubMed ID: 33760202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Macrod1 suppresses diabetic cardiomyopathy via regulating PARP1-NAD
    Liu YT; Qiu HL; Xia HX; Feng YZ; Deng JY; Yuan Y; Ke D; Zhou H; Che Y; Tang QZ
    Acta Pharmacol Sin; 2024 Jun; 45(6):1175-1188. PubMed ID: 38459256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective role of hydrogen sulfide against diabetic cardiomyopathy by inhibiting pyroptosis and myocardial fibrosis.
    Liu M; Zeng C; Zhang Y; Xin Y; Deng S; Hu X
    Biomed Pharmacother; 2024 Jun; 175():116613. PubMed ID: 38657502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.